PHARMANIAGA BERHAD
2026-04-02
Annual Audited Accounts - 31 Dec 2025
PHARMANIAGA BERHAD
2026-03-27
Changes in Director's Interest (Section 219 of CA 2016) - DATO’ SERI DR HJ AWALUDIN BIN SAID
PHARMANIAGA BERHAD
2026-03-16
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
PHARMANIAGA BERHAD
2026-03-16
PHARMANIAGA BERHAD - UPLIFTMENT OF PN17 STATUS
PHARMANIAGA BERHAD
2026-03-16
PHARMANIAGA BERHAD - UPLIFTMENT OF PN17 STATUS
PHARMANIAGA BERHAD
2026-03-13
DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
PHARMANIAGA BERHAD
2026-03-02
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
PHARMANIAGA BERHAD
2026-02-23
Quarterly rpt on consolidated results for the financial period ended 31/12/2025
PHARMANIAGA BERHAD
2026-02-03
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
PHARMANIAGA BERHAD
2026-01-23
Change in Audit Committee - DATUK MOHD ADZAHAR BIN ABDUL WAHID
PHARMANIAGA BERHAD
2026-01-06
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD
PHARMANIAGA BERHAD
2026-01-05
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD
PHARMANIAGA BERHAD
2026-01-02
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
PHARMANIAGA BERHAD
2025-12-31
Change in Nomination and Remuneration Committee - DR IMAM FATHORRAHMAN
PHARMANIAGA BERHAD
2025-12-31
Change in Audit Committee - DR IMAM FATHORRAHMAN
PHARMANIAGA BERHAD
2025-12-31
Change in Boardroom - DR IMAM FATHORRAHMAN
PHARMANIAGA BERHAD
2025-12-31
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD
PHARMANIAGA BERHAD
2025-12-30
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD
PHARMANIAGA BERHAD
2025-12-29
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD
PHARMANIAGA BERHAD
2025-12-04
OTHERS
SALE AND PURCHASE AGREEMENT BETWEEN PHARMANIAGA LOGISTICS SDN. BHD. AND YANG GUANG FURNITURE (SARAWAK) SDN. BHD. (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)
PHARMANIAGA BERHAD
2025-12-03
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
PHARMANIAGA BERHAD
2025-11-18
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD
PHARMANIAGA BERHAD
2025-11-14
OTHERS
CLARIFICATION : PHARMANIAGA Q3 FY2025 FINANCIAL PERFORMANCE
PHARMANIAGA BERHAD
2025-11-13
Quarterly rpt on consolidated results for the financial period ended 30/09/2025
PHARMANIAGA BERHAD
2025-11-12
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD
PHARMANIAGA BERHAD
2025-11-11
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD
PHARMANIAGA BERHAD
2025-11-05
WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR
Members' Voluntary Winding Up of Dormant Subsidiaries :-
i) Bio-Collagen Technologies Sdn Bhd
ii) Paradigm Industry Sdn Bhd
PHARMANIAGA BERHAD
2025-11-05
WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR
Members' Voluntary Winding Up of Dormant Subsidiaries :-
i) Bio-Collagen Technologies Sdn Bhd
ii) Paradigm Industry Sdn Bhd
PHARMANIAGA BERHAD
2025-11-04
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
PHARMANIAGA BERHAD
2025-10-30
OTHERS
SALE AND PURCHASE AGREEMENT BETWEEN PHARMANIAGA LOGISTICS SDN. BHD. AND SINORIA SDN. BHD. (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)